LAVA Therapeutics (LVTX) Short Interest Ratio & Short Volume → Gold Set to EXPLODE! (From Gold Safe Exchange) (Ad) Free LVTX Stock Alerts $3.09 -0.02 (-0.64%) (As of 05/10/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media LAVA Therapeutics Short Interest DataCurrent Short Volume121,300 sharesPrevious Short Volume193,800 sharesChange Vs. Previous Month-37.41%Dollar Volume Sold Short$350,557.00Short Interest Ratio / Days to Cover0.1Last Record DateApril 30, 2024Float Size14,120,000 sharesShort Percent of Float0.86%Today's Trading Volume31,578 sharesAverage Trading Volume155,606 sharesToday's Volume Vs. Average20% Short Selling LAVA Therapeutics ? Sign up to receive the latest short interest report for LAVA Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatLVTX Short Interest Over TimeLVTX Days to Cover Over TimeLVTX Percentage of Float Shorted Over Time Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. LAVA Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024121,300 shares $350,557.00 -37.4%0.9%0.1 $2.89 4/15/2024193,800 shares $567,834.00 -8.4%1.4%0.1 $2.93 3/31/2024211,600 shares $704,628.00 -34.3%1.5%0.1 $3.33 3/15/2024322,100 shares $950,195.00 +476.2%2.3%0.2 $2.95 2/29/202455,900 shares $186,147.00 +448.0%0.5%0 $3.33 2/15/202410,200 shares $20,604.00 -88.4%0.1%0 $2.02 Get the Latest News and Ratings for LVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for LAVA Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/202487,700 shares $146,459.00 +853.3%0.7%0.1 $1.67 1/15/20249,200 shares $15,364.00 +15.0%0.1%0.3 $1.67 12/31/20238,000 shares $12,640.00 -27.3%0.1%0.2 $1.58 12/15/202311,000 shares $17,160.00 -9.8%0.1%0.4 $1.56 11/30/202312,200 shares $18,492.76 -28.7%0.1%0.4 $1.52 11/15/202317,100 shares $25,480.71 -21.6%0.1%0.6 $1.49 10/31/202321,800 shares $25,942.00 -25.3%0.2%0.7 $1.19 10/15/202329,200 shares $40,588.00 -20.4%0.3%1.4 $1.39 9/30/202336,700 shares $53,949.00 -3.2%0.3%1.4 $1.47 9/15/202337,900 shares $64,759.73 -15.0%0.3%1.1 $1.71 8/31/202344,600 shares $78,942.00 +34.7%0.4%0.7 $1.77 8/15/202333,100 shares $59,580.00 -32.0%0.3%0.1 $1.80 7/31/202348,700 shares $91,556.00 -45.2%0.4%0.1 $1.88 7/15/202388,900 shares $176,022.00 +95.4%0.8%0.1 $1.98 6/30/202345,500 shares $92,365.00 -50.7%0.5%0.1 $2.03 6/15/202392,300 shares $180,908.00 +709.7%0.9%0.1 $1.96 5/31/202311,400 shares $21,660.00 -46.2%0.1%0 $1.90 5/15/202321,200 shares $40,280.00 +50.4%0.2%0.4 $1.90 4/30/202314,100 shares $21,291.00 +95.8%0.2%0.2 $1.51 4/15/20237,200 shares $12,816.00 -30.1%0.1%0.1 $1.78 3/31/202310,300 shares $17,098.00 -40.1%0.1%0.2 $1.66 3/15/202317,200 shares $29,584.00 +177.4%0.2%0.3 $1.72 2/28/20236,200 shares $13,888.00 +40.9%0.1%0.1 $2.24 2/15/20234,400 shares $14,872.00 -17.0%0.0%0.1 $3.38 1/31/20235,300 shares $19,292.00 +35.9%0.0%0.2 $3.64 1/15/20233,900 shares $15,015.00 -38.1%0.0%0.1 $3.85 12/30/20226,300 shares $22,050.00 +34.0%0.0%0.1 $3.50 12/15/20224,700 shares $18,142.00 -78.3%0.0%0 $3.86 11/30/202221,700 shares $119,567.00 +130.9%0.1%0 $5.51 11/15/20229,400 shares $50,196.00 No Change0.0%0 $5.34 10/31/20229,400 shares $40,702.00 +213.3%0.0%0 $4.33 10/15/20223,000 shares $11,880.00 -98.1%0.0%0 $3.96 9/30/2022158,800 shares $725,716.00 +14,336.4%1.7%0.2 $4.57 9/15/20221,100 shares $2,574.00 -31.3%0.0%0 $2.34Elon Musk Secret Crypto Plot Exposed (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. LVTX Short Interest - Frequently Asked Questions What is LAVA Therapeutics' current short interest? Short interest is the volume of LAVA Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 121,300 shares of LVTX short. 0.86% of LAVA Therapeutics' shares are currently sold short. Learn More on LAVA Therapeutics' current short interest. What is a good short interest percentage for LAVA Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.86% of LAVA Therapeutics' floating shares are currently sold short. Is LAVA Therapeutics' short interest increasing or decreasing? LAVA Therapeutics saw a decline in short interest in the month of April. As of April 30th, there was short interest totaling 121,300 shares, a decline of 37.4% from the previous total of 193,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is LAVA Therapeutics' float size? LAVA Therapeutics currently has issued a total of 0 shares. Some of LAVA Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. LAVA Therapeutics currently has a public float of 14,120,000 shares. How does LAVA Therapeutics' short interest compare to its competitors? 0.86% of LAVA Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to LAVA Therapeutics: Context Therapeutics Inc. (0.05%), Grifols, S.A. (2.61%), Mainz Biomed (2.57%), NLS Pharmaceutics Ltd. (0.07%), Pharvaris (0.30%), American Oncology Network, Inc. (0.66%), Centogene (0.33%), Concord Medical Services Holdings Limited (0.01%), Shattuck Labs, Inc. (4.29%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short LAVA Therapeutics stock? Short selling LVTX is an investing strategy that aims to generate trading profit from LAVA Therapeutics as its price is falling. LVTX shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against LAVA Therapeutics? A short squeeze for LAVA Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LVTX, which in turn drives the price of the stock up even further. How often is LAVA Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LVTX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Context Therapeutics Short Interest Grifols Short Interest Mainz Biomed Short Interest NLS Pharmaceutics Short Interest Pharvaris Short Interest Tiziana Life Sciences Short Interest 180 Life Sciences Short Interest Aclarion Short Interest Ainos Short Interest Alpha Tau Medical Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LVTX) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 MediaGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHow Biden has already won 2024Porter & CompanyRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable ProsperityThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss Ratings